Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04311710
Title A Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab in Multiple Tumor Types (CheckMate 76U)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Bristol-Myers Squibb

hepatocellular carcinoma

transitional cell carcinoma

lung non-small cell carcinoma

renal cell carcinoma



Ipilimumab + Nivolumab

Ipilimumab + Nivolumab + rHuPH20

Age Groups: senior | adult
Covered Countries USA | ITA

Additional content available in CKB BOOST